Extramedullary plasmacytoma(EMP)is a special type of malignant plasmacytosis,which is complex and heterogeneous.Most EMP patients have poor prognosis and lack a stratified prognostic system or ideal treatment strategy supported by evidence-based medical evidence,which cannot meet clinical needs.In order to improve the understanding of this disease entity,Plasma Cell Disease Group,Chinese Society of Hematology,Chinese Medical Association and Chinese Myeloma Committee-Chinese Hematology Association developed the"Chinese Expert Consensus on the diagnosis and treatment of extramedullary plasmacytoma",which aims to standardize the clinical diagnosis and treatment of EMP and ultimately improve the overall survival of patients with plasmacytoma.
维普
万方数据
